Back
Aclaris Therapeutics Stock Price Chart
Sponsored
How A.I. Could Make Most 21st Century Diseases EXTINCT
Get the name of the stock now... before it's too late >>>
Buy
71
ACRS
Aclaris Therapeutics
Last Price:
8.30
Seasonality Move:
-1.17%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
Doing This Wins 85% Of Market Trades
Click Here To See How It Works- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACRS is experiencing slight buying pressure.
Aclaris Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.33 | Sell |
| 20-day SMA: | 8.45 | Sell |
| 50-day SMA: | 8.57 | Sell |
| 200-day SMA: | 13.54 | Sell |
| 8-day EMA: | 8.34 | Sell |
| 20-day EMA: | 8.44 | Sell |
| 50-day EMA: | 9.08 | Sell |
| 200-day EMA: | 12.24 | Sell |
Aclaris Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 44.78 | Sell |
| Chaikin Money Flow: | 14264 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.17 - 8.91) | Sell |
| Bollinger Bands (100): | (7.68 - 14.56) | Sell |
Aclaris Therapeutics Technical Analysis
| May-15 | May-16 | May-17 | May-18 | May-19 | May-22 | May-23 | May-24 | May-25 | May-26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aclaris Therapeutics Stock
Is Aclaris Therapeutics Stock a Buy?
- Aclaris Therapeutics share price is 8.29 while ACRS 8-day simple moving average is 8.33, which is a Sell signal.
- The stock price of ACRS is 8.29 while Aclaris Therapeutics 20-day SMA is 8.45, which makes it a Sell.
- Aclaris Therapeutics 50-day simple moving average is 8.57 while ACRS share price is 8.29, making it a Sell technically.
- ACRS stock price is 8.29 and Aclaris Therapeutics 200-day simple moving average is 13.54, creating a Sell signal.
ACRS Technical Analysis vs Fundamental Analysis
Buy
71
Aclaris Therapeutics (ACRS)
is a Buy
Is Aclaris Therapeutics a Buy or a Sell?
-
Aclaris Therapeutics stock is rated a Buy
The current Aclaris Therapeutics [ACRS] share price is $8.29. The Score for ACRS is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Aclaris Therapeutics Stock Info
Market Cap:
585.93M
Price in USD:
8.29
Share Volume:
299.54K
Aclaris Therapeutics 52-Week Range
52-Week High:
18.96
52-Week Low:
5.77
Buy
71
Aclaris Therapeutics (ACRS)
is a Buy
Aclaris Therapeutics Share Price Forecast
-
What is the Aclaris Therapeutics stock price today?
The Aclaris Therapeutics stock price is 8.29 USD today. -
Will ACRS stock go up or go down?
Aclaris Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aclaris Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aclaris Therapeutics is not overvalued.
Is Aclaris Therapeutics Stock a Buy?
- Aclaris Therapeutics share price is 8.29 while ACRS 8-day exponential moving average is 8.34, which is a Sell signal.
- The stock price of ACRS is 8.29 while Aclaris Therapeutics 20-day EMA is 8.44, which makes it a Sell.
- Aclaris Therapeutics 50-day exponential moving average is 9.08 while ACRS share price is 8.29, making it a Sell technically.
- ACRS stock price is 8.29 and Aclaris Therapeutics 200-day simple moving average is 12.24, creating a Sell signal.
Fundamental Analysis of Aclaris Therapeutics
Is Aclaris Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.44 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Aclaris Therapeutics
Should I short Aclaris Therapeutics stock?
- ACRS Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Aclaris Therapeutics is a Sell
- Aclaris Therapeutics Relative Strength Index (RSI) is 44.78, which suggest Aclaris Therapeutics is oversold
- The Bollinger Bands (25) for Aclaris Therapeutics is (8.17 - 8.91), which suggest Aclaris Therapeutics is a Sell
- The Bollinger Bands (100) for Aclaris Therapeutics is (7.68 - 14.56), which suggest Aclaris Therapeutics is a Sell
* Aclaris Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.